Amneal Announces Submission of New Drug Application to the U.S. FDA for IPX203 for the Treatment of Parkinson’s Disease Read more
Spatial Biology CRO Flagship Biosciences Acquires Pharma Services Business from Interpace Biosciences Read more
Guardant Health Expands Strategic Collaboration With Merck KGaA, Darmstadt, Germany, to Help Accelerate Development of Precision Oncology Therapeutics Read more
OKYO Pharma Plans Q4 2022 IND Filing of OK-101 to treat Dry Eye Disease with Subsequent Phase 2 Initiation Alongside Peptide Manufacturing Partner, AmbioPharm Read more
Novartis Scemblix, with novel mechanism of action, approved by the European Commission for adult patients with chronic myeloid leukemia Read more
Zerion Pharma and Insud Pharma announce collaboration to develop Dispersome formulations of marketed drug products Read more